Glycaemic control IS important

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Day, C.
	Articles by Bailey, C. J
	Search for Related Content

Social Bookmarking

	What's this?

Caroline Day

Day Diabetes Research Group School of Life and Health Sciences, Aston University Aston Triangle, Birmingham, B4 7ET. UK, cday{at}mededuk.com

Clifford J Bailey

References

Wingard DL, Barrett-Connor E. Heart disease and diabetes. National Diabetes Data Group. Diabetes in America, 2nd edn, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 1995, 429-48. NIH publication number 95-1468. Bethesda, USA.

Kannel WB, McGee EL Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.[Abstract/Free Full Text]

Haffner SM, Lehto S., Ronnemaa T. et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med 1998;339:229-34.[Abstract/Free Full Text]

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Stratton IM, Adler AI, Neil HAW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:305-12.[Free Full Text]

Selvin E., Marinopoulos S., Berkenblit G. et al. Meta-analysis; glycosylated haemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.[Abstract/Free Full Text]

Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-8.[Abstract/Free Full Text]

Khaw KT, Wareham N., Bingham S. et al. Association of hemoglobin A1C with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004;141:413-20.[Abstract/Free Full Text]

DeFronzo RA, Mandarino L., Ferrannini E. Metabolic and molecular pathogenesis of type 2 diabetes mellitus in International Textbook of Diabetes Mellitus, 3rd edn. RA Defronzo, E Ferrannini, H Keen, P Zimmet (eds). Wiley, Chichester, 2004;389-438.

The DECODE study group. Is the current definition of diabetes relevant to mortality risk from all causes and cardiovascular and non cardiovascular diseases? Diabetes Care 2003;26:688-96.[Abstract/Free Full Text]

Nathan DM, Davidson MB, DeFronzo RA et al. Impaired fasting glucose and impaired glucose tolerance. Implications for care. Diabetes Care 2007;30:753-9.[Free Full Text]

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA 2002;287:2570-81.[Abstract/Free Full Text]

International Diabetes Federation: guideline for the management of post-meal blood glucose. www.idf.org. 2007 (accessed October 2007).

Cleland JGF, Atkin SL Thiazolidinediones, deadly sins, surrogates, and elephants. Lancet 2007;370:1103-04. 15. 5. Montori VM, Gandhi GY, Guyatt GH Patient-important outcomes in diabetes - time for consensus. Lancet 2007;370:1104-06.[CrossRef][Medline] [Order article via Infotrieve]